307750 — Kukjeon Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩211bn
- KR₩233bn
- KR₩122bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -33.9 | -3,317 | 4,038 | 8,877 | 4,692 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -4.3 | 9,689 | 1,839 | -7,704 | 1,496 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.974 | 12,299 | -3,938 | -8,633 | -9,602 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -37.2 | 19,647 | 3,042 | -6,019 | -345 |
Capital Expenditures | — | -2,516 | -10,418 | -23,767 | -38,020 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -1,000 | -2,617 | -22,161 | -52,866 | 13,705 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,000 | -5,133 | -32,579 | -76,633 | -24,314 |
Financing Cash Flow Items | — | 20 | 0 | -5.6 | 400 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | -5,597 | 38,856 | 85,100 | 14,106 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1,037 | 8,916 | 9,320 | 2,447 | -10,554 |